Evidence map›Paper›PMID 27448057›Full record

ReviewNature reviews. Endocrinology2016

Skeletal muscle mitochondria as a target to prevent or treat type 2 diabetes mellitus.

Matthijs K C Hesselink, Vera Schrauwen-Hinderling, Patrick Schrauwen

3 registry-linked trialsAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Endocrinology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 152 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
152citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03323294 completednot on this mapstarted 2017, after this paper: background citation

Bioenergetics and Metabolism in Pediatric Populations

TypeobservationalSponsorArkansas Children's Hospital Research InstituteRan2017 to 2024Enrolled79ConditionsObesity, Type 2 Diabetes Mellitus, Insulin Resistance
NCT06080581 completednot on this mapstarted 2023, after this paper: background citation

Mitochondrial Derangements Driving Muscle Insulin Resistance in Humans

TypeobservationalSponsorRigshospitalet, DenmarkRan2023 to 2024Enrolled30ConditionsMitochondrial Myopathies, Mitochondrial Diseases, Mitochondrial Disorders
NCT06080594 nacompletednot on this mapstarted 2024, after this paper: background citation

Exercise-mediated Rescue of Mitochondrial Derangements Driving Insulin Resistance in Humans (EX-MITO-DYS-IR)

TypeinterventionalSponsorRigshospitalet, DenmarkRan2024 to 2025Enrolled11ConditionsMitochondrial Myopathies, Mitochondrial Diseases, Mitochondrial DisordersArmsHigh-intensity exercise training
3 · Its place in the literature

Who cites it

152 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Development of aNature communications · 2024
    Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

92 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Matthijs K C HesselinkDepartment of Human Biology and Human Movement Sciences, Maastricht University Medical Center, Universiteitsingel 50, 6229 ER, Maastricht, Netherlands.
Vera Schrauwen-HinderlingDepartment of Human Biology and Human Movement Sciences, Maastricht University Medical Center, Universiteitsingel 50, 6229 ER, Maastricht, Netherlands.
Patrick SchrauwenDepartment of Human Biology and Human Movement Sciences, Maastricht University Medical Center, Universiteitsingel 50, 6229 ER, Maastricht, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Low levels of physical activity and the presence of obesity are associated with mitochondrial dysfunction. In addition, mitochondrial dysfunction has been associated with the development of insulin resistance and type 2 diabetes mellitus (T2DM). Although the evidence for a causal relationship between mitochondrial function and insulin resistance is still weak, emerging evidence indicates that boosting mitochondrial function might be beneficial to patient health. Exercise training is probably the most recognized promoter of mitochondrial function and insulin sensitivity and hence is still regarded as the best strategy to prevent and treat T2DM. Animal data, however, have revealed several new insights into the regulation of mitochondrial metabolism, and novel targets for interventions to boost mitochondrial function have emerged. Importantly, many of these targets seem to be regulated by factors such as nutrition, ambient temperature and circadian rhythms, which provides a basis for nonpharmacological strategies to prevent or treat T2DM in humans. Here, we will review the current evidence that mitochondrial function can be targeted therapeutically to improve insulin sensitivity and to prevent T2DM, focusing mainly on human intervention studies.

Indexed as

Circadian RhythmDiet TherapyExercise TherapyInsulin ResistanceTemperatureCaloric RestrictionCarnitineCryotherapyDiabetes Mellitus, Type 2Dietary SupplementsExerciseHumansMitochondria, MuscleMuscle, SkeletalObesitySleepCarnitine

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.